PROGRESSIVE PULMONARY FIBROSIS
Clinical trials for PROGRESSIVE PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Six-year safety check for inhaled lung fibrosis drug begins
Disease control ENROLLING_BY_INVITATIONThis study follows people who were in previous trials of an inhaled medication called treprostinil for progressive lung scarring diseases. It aims to check the long-term safety and side effects of the drug over up to six years. Only people who completed specific earlier studies a…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Major trial tests new hope for slowing deadly lung scarring
Disease control OngoingThis large, late-stage study is testing whether an investigational drug called BMS-986278 can slow the progression of pulmonary fibrosis, a serious condition that causes permanent lung scarring. It will involve over 1,000 participants and compare the drug's effects against a plac…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New scan could reveal if lung scarring drugs are working
Knowledge-focused OngoingThis study is testing a special type of MRI scan to see if it can detect changes in lung scarring. It will enroll 60 adults with progressive lung scarring who are starting or considering anti-scarring medication. Participants will have the MRI scan before starting treatment and a…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC